查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1623294

經子宮頸輸卵管不孕法的全球市場規模:各產品，各用途，各地區，範圍及預測

Global Transcervical Tubal Sterilization Market Size By Product(tubal ligation and transcervical implants), By Application(hospitals, clinics, and others), and Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

經子宮頸輸卵管不孕症方法市場規模及預測

近年來，經子宮頸輸卵管不孕症的市場規模以顯著的成長率快速成長，預計在2021年至2028年的預測期內，該市場將顯著成長。

生活方式的改變、意識的提高、避孕技術和可支配收入的增加推動了經子宮頸輸卵管不孕症市場的成長。全球經子宮頸輸卵管不孕症市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

經子宮頸輸卵管不孕症的全球市場定義

絕育通常被選擇作為永久性避孕的方法。傳統方法需要在手術室麻醉下進行手術，有恢復期並會留下疤痕。經子宮頸絕育或輸卵管阻塞是一種微創、非切口的輸卵管結紮手術替代方案。與腹腔鏡手術相比，經子宮頸子宮腔鏡避孕不需要手術室，麻醉用量少，恢復期短，性價比更高。

經子宮頸輸卵管不孕症具有良好的輸卵管通路、高閉塞率、高患者可接受性，並且在門診環境中進行。這些因素的結合提供了比傳統腹腔鏡方法顯著的優勢，並且可能具有成本效益。

經子宮頸輸卵管不孕症的全球市場概況

全球避孕意識的提高預計將推動市場成長。推動市場的關鍵因素是這個過程不會像避孕藥那樣表現出副作用，並且是最安全的避孕方法。此外，各個市場參與者為加強絕育手術而取得的技術進步以及市場參與者持續開展的宣傳活動，都有助於為女性提供的經子宮頸絕育手術的不斷增加，我們專注於改進和品質提高。此外，該手術不需要切口，可以在辦公室進行。因此，它具有成本效益和時間效率，需要最少的麻醉甚至不需要麻醉，甚至可以在患有廣泛盆腔粘連的女性中進行，術後疼痛較少，並且具有排除腹腔鏡或開放手術的合併症，甚至可以由女性完成。

併發症風險和恢復期長等因素是可能對市場成長產生負面影響的課題。此外，諸如過程之類的因素是不可逆轉的。由於它是一種永久性方法，只有一些變化是可逆的，因此缺乏對性傳染病的保護是限制市場成長的因素。手術後 12 週內需要避孕（直到確認輸卵管閉塞）、確認輸卵管閉塞的設備和成像測試的費用以及微插入物的導電性使得隨後的骨盆閉塞變得困難。 、單側輸卵管閉塞的高風險以及需要適當的陰道手術培訓以盡量減少潛在的併發症，這些都是阻礙經子宮頸絕育市場的因素。

人們對計劃生育的認識不斷提高，以及與經子宮頸輸卵管不孕相關的新技術的進步，以降低性傳染病的風險，可能會在預測期內創造新的機會。

目錄

第1章 經子宮頸輸卵管不孕法的全球市場:簡介

  • 市場概要
  • 調查範圍
  • 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源一覽

第4章 經子宮頸輸卵管不孕法的全球市場展望

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力分析模式
  • 價值鏈分析

第5章 經子宮頸輸卵管不孕法的全球市場:各產品

  • 概要
  • 輸卵管結紮術
  • 經子宮頸植入

第6章 經子宮頸輸卵管不孕法的全球市場:各用途

  • 概要
  • 醫院
  • 診所
  • 其他

第7章 經子宮頸輸卵管不孕法的全球市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區
    • 中東·非洲
    • 南美

第8章 經子宮頸輸卵管不孕法的全球市場:競爭情形

  • 概要
  • 各公司的市場排行榜
  • 主要的發展策略

第9章 企業簡介

  • Ethicon
  • Medtronic
  • Applied Medical
  • Richard Wolf
  • Bayer AG
  • Stryker
  • LiNA Medical
  • ConMed
  • Microline Surgical
  • Apollo Endosurgery

第10章 附錄

  • 相關調查
簡介目錄
Product Code: 21654

Transcervical Tubal Sterilization Market Size And Forecast

Transcervical Tubal Sterilization Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e., 2021 to 2028.

The transcervical Tubal sterilization market growth is driven by changing lifestyles, increased awareness, birth control techniques, and increased disposable income. The Global Transcervical Tubal Sterilization Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Transcervical Tubal Sterilization Market Definition

Sterilization is often chosen as a method of permanent contraception. Traditional approaches involve surgery under anesthesia in an operating room and are associated with a recovery period and scars. Transcervical sterilization or tubal occlusion is an incision-free, minimally invasive procedure alternative to surgical tubal ligation. Compared with laparoscopic surgery, transcervical hysteroscopic sterilization does not need to be performed in an operating room, requires less anesthesia, has a shorter recovery period, and is more cost-effective.

Transcervical tubal sterilization methods have good tubal access, occlusion rates, high patient acceptability and are performed in an outpatient environment. This combination of factors may offer significant benefits to traditional laparoscopic approaches and render them more cost-effective.

Global Transcervical Tubal Sterilization Market Overview

The growing awareness for birth control across the globe is expected to boost the growth of the market. The primary factor that plays a significant role in driving the market is that this process does not show any side effects that consist of birth control pills and is the safest contraceptive method. Further, the technological advancements by the various market players to enhance the procedure of sterilization and the awareness drives by the market players currently done are focused on constant up-gradation and improvement of the quality of operation of Transcervical Tubal Sterilization being provided to the women. Moreover, the factor such as there's no incision involved in the procedure can be performed in an office setting. Hence, it is more cost- and time-effective, has Minimal to no anesthetic requirements, can be performed in women with extensive pelvic adhesions, causes Less post-operative pain, it can be completed in women with co-morbidities that preclude laparoscopy or laparotomy are responsible for the growth of Global Transcervical Tubal Sterilization Market during the forecast period.

The factors such as the risk of complications and long recovery period are challenges that may negatively impact the market's growth. Moreover, the element such as process is irreversible. It is a permanent method, and only a few changes are reversible-the absence of protection against sexually transmitted diseases restraint the market's growth. Need for contraception for 12 weeks post-procedure (until the tubal occlusion is confirmed); The expense of device and imaging study to ensure tubal occlusion; Electrical conductivity of micro-insert limits the use of electrocautery during subsequent pelvic procedures; Higher risk of unilateral tubal occlusion; The need for adequate vaginal surgical training to minimize potential complications are some additional factors that can hinder the global transcervical tubal sterilization market.

The growing awareness about family planning and the advancement of new technologies involved in Transcervical Tubal Sterilization that reduce the risk of STDs might generate new opportunities within the forecast period.

Global Transcervical Tubal Sterilization Market: Segmentation Analysis

The Global Transcervical Tubal Sterilization Market is segmented based on Product, Application, and Geography.

Transcervical Tubal Sterilization Market by Product

  • Tubal Ligation
  • Transcervical Implants

Based on the product, the global transcervical tubal sterilization market is bifurcated into tubal ligation and transcervical implants. Tubal ligation dominates this segment of the global transcervical tubal sterilization market, owing to governments' sponsorship to control the country's populations. This kind of female sterilization needs a laparoscopic incision to be made in the abdominal area to surgically block the fallopian tubes by cutting, tying, or using clamps. This kind of sterilization procedure is effective immediately. The transcervical implant segment is expected to witness steady growth in the forecasted period. As one of the main factors for the development of the market, this procedure involves no surgical incision and hence can be performed in an office setting.

Transcervical Tubal Sterilization Market by Application

  • Hospitals
  • Clinics
  • Others

Based on application, the global transcervical tubal sterilization market is bifurcated into hospitals, clinics, and others. Hospitals dominate this segment owing to prefer in emerging countries not able to afford treatment in clinics that are usually privately managed though clinics are witnessing a steady rise in the global transcervical tubal sterilization market. Moreover, most clinics do not offer such procedures, which are available in almost all of the hospitals everywhere. The presence of clinics is also a factor why the hospital's segment has the majority share in this segment; the number of hospitals is enormous compared to the number of hospitals.

Transcervical Tubal Sterilization Market by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on geography, the global transcervical tubal sterilization market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the world. North American market leads the transcervical tubal sterilization market in terms of revenue share, owing to awareness among the general population and increasing promotion for family planning activities from the government. Europe market held the second largest market share of the global transcervical tubal sterilization market in terms of sales, followed by the market in the Asia Pacific.

Key Players

The "Global Transcervical Tubal Sterilization Market" study report will provide valuable insight emphasizing the global market. The major players in the market are

Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the players mentioned above globally.

Report Scope

Report Attributes

Report Attributes

Study Period

2017-2028

Base Year

2020

Forecast Period

2021-2028

Historical Period

2017-2019

Key Companies Profiled

Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

Segments Covered

By Product, By Application, and By Geography.

Customization scope

Free report customization (equivalent up to 4 analyst's working days) with purchase. Addition or alteration to country, regional & segment scope

Top Trending Reports

Transportation Battery Market Size And Forecast

Training Dancewear Market Size And Forecast

Global Transcervical Tubal Sterilization Market: Research Methodology

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our

sales team

Reasons to Purchase this Report:

  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
  • The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes an in-depth analysis of the market of various perspectives through Porter's five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post sales analyst support

Customization of the Report

  • In case of any

Queries or Customization Requirements

Frequently Asked Questions

What are the key driving factors for the growth of the Transcervical Tubal Sterilization Market?

  • The transcervical Tubal sterilization market growth is driven by changing lifestyles, increased awareness, birth control techniques, and increased disposable income.

What are the top players operating in the Transcervical Tubal Sterilization Market?

  • Ethicon, Medtronic, Applied Medical, Richard Wolf, Bayer AG, Stryker, LiNA Medical, ConMed, Microline Surgical, and Apollo Endosurgery.

What segments are covered in the Transcervical Tubal Sterilization Market?

  • The Global Transcervical Tubal Sterilization Market is segmented based on Product, Application, and Geography.
  • The sample report of the Transcervical Tubal Sterilization Market can be obtained on demand from the website. Also, the 24*7 chat support & direct call services are provided to procure the sample report.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porter Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY PRODUCT

  • 5.1 Overview
  • 5.2 Tubal Ligation
  • 5.3 Transcervical Implants

6 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY APPLICATION

  • 6.1 Overview
  • 6.2 Hospitals
  • 6.3 Clinics
  • 6.4 Others

7 GLOBAL TRANSCERVICAL TUBAL STERILIZATION BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Rest of the World
    • 7.5.1 Middle East and Africa
    • 7.5.2 Latin America

8 GLOBAL TRANSCERVICAL TUBAL STERILIZATION MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Ranking
  • 8.3 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Ethicon
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 Medtronic
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Applied Medical
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Richard Wolf
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Bayer AG
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Stryker
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Development
  • 9.7 LiNA Medical
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 ConMed
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Microline Surgical
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Development
  • 9.10 Apollo Endosurgery
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Development

10 Appendix

  • 10.1 Related Research